(MedPage Today) -- The FDA has approved levomilnacipran (Fetzima), a single-enantiomer version of the fibromyalgia drug milnacipran (Savella), for treating major depression, its developers said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment